{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:41:22Z","timestamp":1787071282847,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB) poses a significant public health challenge, particularly because it can exist in an asymptomatic latent phase. Latent TB infection indicates the presence of\n                      <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic>\n                      without clinical symptoms. Effectively distinguishing between active and latent TB is essential, especially in regions with high TB prevalence, as it may help reduce transmission rates. This study aims to evaluate C1q as a potential biomarker for differentiating active TB from latent forms.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective cross-sectional study was conducted from January 2017 to February 2018, involving HIV-negative adults aged 18 and older attending TB clinics. Participants were categorized based on clinical symptoms, imaging results, and laboratory tests into active or latent TB. Blood samples were collected to assess serum C1q levels, which were then compared between the two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Out of 81 patients referred for TB evaluation, 38 were diagnosed with active TB. The overall median C1q level was 6.46 \u03bcg\/ml (interquartile range 4.66\u201310). The active TB group exhibited significantly elevated C1q levels (10.21 \u03bcg\/ml) compared to the latent TB group (6.03 \u03bcg\/ml,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The area under the receiver operating characteristic curve for C1q in distinguishing active from latent TB was 0.74 (95% confidence interval, 0.63\u20130.85), with sensitivity varying between 61% and 82% at different threshold values.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>C1q shows potential as a reliable and easily obtainable biomarker for differentiating active TB from latent infection, demonstrating high sensitivity. These results underscore the need for further research to explore the clinical application of C1q in TB diagnostics.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijmy.ijmy_194_24","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T15:01:40Z","timestamp":1734620500000},"page":"404-409","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["C1q Levels: A Reliable Biomarker for Differentiating Active and Latent Tuberculosis Infection"],"prefix":"10.4103","volume":"13","author":[{"given":"Sepideh","family":"Darougar","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-8940","authenticated-orcid":false,"given":"Afshin","family":"Moniri","sequence":"additional","affiliation":[{"name":"Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvaneh","family":"Baghaei","sequence":"additional","affiliation":[{"name":"Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esmaeil","family":"Mortaz","sequence":"additional","affiliation":[{"name":"Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"},{"name":"Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makan","family":"Sadr","sequence":"additional","affiliation":[{"name":"Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arad","family":"Moniri","sequence":"additional","affiliation":[{"name":"Virology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Marjani","sequence":"additional","affiliation":[{"name":"Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Tabarsi","sequence":"additional","affiliation":[{"name":"Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,19]]},"reference":[{"key":"R2-20241219","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1513\/AnnalsATS.201511-750ED","article-title":"\u201cLatent tuberculosis infection\u201d is a term that should go dormant, and the significance of latent tuberculosis should be rethought","volume":"13","author":"Schraufnagel","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R3-20241219","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/ijmy.ijmy_82_17","article-title":"Screening of health-care workers for latent tuberculosis infection in a tertiary care hospital","volume":"6","author":"Janagond","year":"2017","journal-title":"Int J Mycobacteriol"},{"key":"R4-20241219","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4103\/bbrj.bbrj_71_19","article-title":"Evaluation of the therapeutic, diagnostic, and prognostic means currently applied to counter the surge of tuberculosis","volume":"3","author":"Maes","year":"2019","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R5-20241219","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1038\/emi.2016.10","article-title":"Updates on the risk factors for latent tuberculosis reactivation and their managements","volume":"5","author":"Ai","year":"2016","journal-title":"Emerg Microbes Infect"},{"key":"R7-20241219","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4046\/trd.2016.79.4.201","article-title":"Tuberculosis infection and latent tuberculosis","volume":"79","author":"Lee","year":"2016","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"R8-20241219","doi-asserted-by":"crossref","first-page":"442","DOI":"10.4103\/ijmy.ijmy_196_22","article-title":"Outcomes of latent tuberculosis infection treatment in Istanbul","volume":"11","author":"G\u00fcner","year":"2022","journal-title":"Int J Mycobacteriol"},{"key":"R9-20241219","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1378\/chest.11-0992","article-title":"Challenges of interferon-\u03b3 release assay conversions in serial testing of health-care workers in a TB control program","volume":"142","author":"Fong","year":"2012","journal-title":"Chest"},{"key":"R10-20241219","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1128\/JCM.00730-12","article-title":"Investigation of false-positive results given by the QuantiFERON-TB gold in-tube assay","volume":"50","author":"Slater","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R11-20241219","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0140-6736(15)01316-1","article-title":"A blood RNA signature for tuberculosis disease risk: A prospective cohort study","volume":"387","author":"Zak","year":"2016","journal-title":"Lancet"},{"key":"R12-20241219","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1056\/NEJMoa1303657","article-title":"Diagnosis of childhood tuberculosis and host RNA expression in Africa","volume":"370","author":"Anderson","year":"2014","journal-title":"N Engl J Med"},{"key":"R13-20241219","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1183\/13993003.01012-2016","article-title":"Correlates of tuberculosis risk: Predictive biomarkers for progression to active tuberculosis","volume":"48","author":"Petruccioli","year":"2016","journal-title":"Eur Respir J"},{"key":"R14-20241219","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4103\/ijmy.ijmy_44_21","article-title":"Evaluation of a new interferon gamma release assay, in comparison to tuberculin skin tests and quantiferon tuberculosis goldplus for the detection of latent tuberculosis infection in children from a high tuberculosis burden setting","volume":"10","author":"Benachinmardi","year":"2021","journal-title":"Int J Mycobacteriol"},{"key":"R15-20241219","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4103\/bbrj.bbrj_51_19","article-title":"Predictive value of serum adenosine deaminase levels in prospect of tubercular infections","volume":"3","author":"Lende","year":"2019","journal-title":"Biomed Biotechnol Res J (BBRJ)"},{"key":"R16-20241219","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.molimm.2015.05.010","article-title":"C1q, antibodies and anti-C1q autoantibodies","volume":"68","author":"Beurskens","year":"2015","journal-title":"Mol Immunol"},{"key":"R17-20241219","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/cei.12952","article-title":"Production of complement components by cells of the immune system","volume":"188","author":"Lubbers","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"R18-20241219","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molimm.2016.09.001","article-title":"The production and secretion of complement component C1q by human mast cells","volume":"78","author":"van Schaarenburg","year":"2016","journal-title":"Mol Immunol"},{"key":"R19-20241219","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/cmi.2008.2","article-title":"The classical and regulatory functions of C1q in immunity and autoimmunity","volume":"5","author":"Lu","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"R20-20241219","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1177\/1753425910396252","article-title":"Complement and non-complement activating functions of C1q: A prototypical innate immune molecule","volume":"18","author":"Nayak","year":"2012","journal-title":"Innate Immun"},{"key":"R21-20241219","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/gene.2010.51","article-title":"Human gene expression profiles of susceptibility and resistance in tuberculosis","volume":"12","author":"Maertzdorf","year":"2011","journal-title":"Genes Immun"},{"key":"R22-20241219","doi-asserted-by":"crossref","first-page":"e92340","DOI":"10.1371\/journal.pone.0092340","article-title":"Increased complement C1q level marks active disease in human tuberculosis","volume":"9","author":"Cai","year":"2014","journal-title":"PLoS One"},{"key":"R23-20241219","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3389\/fimmu.2018.02427","article-title":"Complement component C1q as serum biomarker to detect active tuberculosis","volume":"9","author":"Lubbers","year":"2018","journal-title":"Front Immunol"},{"key":"R24-20241219","doi-asserted-by":"crossref","first-page":"e38080","DOI":"10.1371\/journal.pone.0038080","article-title":"Discriminating active from latent tuberculosis in patients presenting to community clinics","volume":"7","author":"Sandhu","year":"2012","journal-title":"PLoS One"},{"key":"R25-20241219","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/ijmy.ijmy_30_19","article-title":"Blood cytokine responses to early secreted protein antigen-6\/culture filtrate protein-10 tuberculosis antigens 2 months after antituberculosis treatment among patients with drug-susceptible pulmonary tuberculosis","volume":"8","author":"Mvungi","year":"2019","journal-title":"Int J Mycobacteriol"},{"key":"R26-20241219","doi-asserted-by":"crossref","first-page":"8509127","DOI":"10.1155\/2018\/8509127","article-title":"Biomarkers in infectious diseases","volume":"2018","author":"Hwang","year":"2018","journal-title":"Dis Markers"},{"key":"R27-20241219","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0090-1229(82)90073-3","article-title":"High C1q levels, low C1s\/C1q ratios, and high levels of circulating immune complexes in kala-azar","volume":"23","author":"Kager","year":"1982","journal-title":"Clin Immunol Immunopathol"}],"container-title":["The International Journal of Mycobacteriology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_194_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:44:06Z","timestamp":1787067846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijmy.ijmy_194_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmy.ijmy_194_24","relation":{},"ISSN":["2212-5531","2212-554X"],"issn-type":[{"value":"2212-5531","type":"print"},{"value":"2212-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"2024-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}